HIV capsid inhibitor offers new option for people with highly resistant HIV
Underlying health conditions play a major role in increased risk of hospitalisation with COVID-19 in people with HIV
Depression, anxiety and loneliness can be improved with mindfulness audio lessons
Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda
Pronounced racial HIV disparities persist in the US, with some signs of slow improvement
African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir
Alendronate can prevent bone loss in people starting HIV treatment
Reformulated islatravir implant should provide PrEP for over a year
Large numbers now on Descovy PrEP in the United States
